Open Access Open Access  Restricted Access Subscription or Fee Access

Use of Nutraceuticals in IBD

Rajveer Bhaskar, Monika Ola, Kajal Sharma, Toyesh Chaudhari


The clinical course of inflammatory bowel disease is classified by time interval of chronic disease with duration of active inflammation, Malabsorption and malnutrition are most seeing problems in person who is suffering from IBD. It is seen that nutritional product in form of nutraceuticals are conventional treatment to solve the problem of IBD. Nutraceutical like probiotics, glutamine, transforming growth factor β2 are used in IBD. Future studies are needed to focus on potential roles of functional food sand diet to control and prevent IBD. In western countries, it is the most facing problems by the peoples because of the high fat and high carbohydrate consumption; therefore nutraceuticals provide them with needed supplements for their body regulation. So nutraceutical is one of the good formulations for IBD. Even Indian people suffering from IBD and India have highest patient with IBD across the world. So nutrition like vitamins, calcium, iron etc. are supplied in form of nutraceutical sin India. The product like capsules of omega3, vitamins, even are present in form of powders. So we can say nutraceutical is good way to overcome IBD.


nutraceutical, inflammatory bowel disease, new therapeutic drug, diet, protein network

Full Text:



Kane, S.V. and Robinson, A., 2010. Understanding adherence to medication in ulcerative colitis–innovative thinking and evolving concepts. Alimentary pharmacology & therapeutics, 32(9), pp.1051–1058.

Larussa, T., Imeneo, M. and Luzza, F., 2017. Potential role of nutraceutical compounds in inflammatory bowel disease. World journal of gastroenterology, 23(14), p.2483.

Jahanian, E., Mahdavi, A.H., Asgary, S., Jahanian, R. and Tajadini, M.H., 2019. Effect of dietary supplementation of mannanoligosaccharides on hepatic gene expressions and humoral and cellular immune responses in aflatoxin-contaminated broiler chicks. Preventive veterinary medicine, 168, pp.9–18.

Taus, M., Busni, D., Petrelli, M.D. and Nicolai, A., 2009. New nutritional approach to inflammatory bowel disease: the nutraceuticals. Mediterranean Journal of Nutrition and Metabolism, 1(3), pp.145–148.

Baumgart, D.C. and Sandborn, W.J., 2007. Inflammatory bowel disease: clinical aspects and established and evolving therapies. The Lancet, 369(9573), pp.1641–1657.

Kalra, E.K., 2003. Nutraceutical-definition and introduction. Aaps Pharmsci, 5(3), pp.27–28.

Mouli, V.P. and Anantha krishnan, A.N., 2014. Vitamin D and inflammatory bowel diseases. Alimentary pharmacology & therapeutics, 39(2), pp.125–136.

Preuss, C., K Das, M. and V Pathak, Y., 2014. Genomics and natural products: role of bioinformatics and recent patents. Recent patents on biotechnology, 8(2), pp.144–151.

Peña-Romero, A.C., Navas-Carrillo, D., Marín, F. and Orenes-Piñero, E., 2018. The future of nutrition: nutrigenomics and nutrigenetics in obesity and cardiovascular diseases. Critical reviews in food science and nutrition, 58(17), pp.3030–3041.

Kohsuke, A. and Hayamizu, M., 2010. Application of Genomics and Bioinformatics Analysis in Exploratory Study of Functional Foods. Genomics, Proteomics, and Metabolomics in Nutraceuticals and Functional Foods, p.61.


  • There are currently no refbacks.